NCT06106282View on ClinicalTrials.gov

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 12, 2023

Primary Completion Date

July 12, 2028

Study Completion Date

July 12, 2028

Conditions
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Hormone Receptor-Positive Breast Carcinoma
Interventions
OTHER

Non-Interventional Study

Non-Interventional Study

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06106282 - Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) | Biotech Hunter | Biotech Hunter